{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:40:23Z","timestamp":1785577223457,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cveq.2005.12.025","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:08:25Z","timestamp":1168423705000},"page":"e37-e45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fluphenazine-Induced Extrapyramidal Side Effects in a Horse"],"prefix":"10.1016","volume":"22","author":[{"given":"Michael","family":"Brashier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2005.12.025_bib1","first-page":"79","article-title":"Management of neuroleptic malignant syndrome with anticholinergic medication","volume":"41","author":"Hasan","year":"1999","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.cveq.2005.12.025_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-3306.1990.tb04227.x","article-title":"Fluphenazine induced Parkinson-like syndrome in a horse","volume":"22","author":"Brewer","year":"1990","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2005.12.025_bib3","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"399","article-title":"Drugs and the treatment of psychiatric disorders\u2014psychosis and anxiety","author":"Baldessarini","year":"1996"},{"key":"10.1016\/j.cveq.2005.12.025_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.cveq.2005.12.025_bib5","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2460\/javma.1989.195.08.1128","article-title":"Extrapyramidal side effects caused by fluphenazine decanoate in a horse","volume":"195","author":"Kauffman","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2005.12.025_bib6","first-page":"326","article-title":"Pharmacologic treatment of schizophrenia","volume":"13","author":"Levinson","year":"1991","journal-title":"Clin Ther"},{"key":"10.1016\/j.cveq.2005.12.025_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2165\/00003088-198611010-00003","article-title":"Plasma level monitoring of antipsychotic drugs. Clinical utility","volume":"11","author":"Dahl","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cveq.2005.12.025_bib8","first-page":"34","article-title":"Pharmacokinetics of neuroleptic drugs and the utility of plasma level monitoring","volume":"5","author":"Dahl","year":"1988","journal-title":"Psychopharmacol Ser"},{"key":"10.1016\/j.cveq.2005.12.025_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004714-198510000-00003","article-title":"The strategy and value of neuroleptic drug monitoring","volume":"5","author":"Curry","year":"1985","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.cveq.2005.12.025_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0166-4328(93)90064-W","article-title":"Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats","volume":"57","author":"Liminga","year":"1993","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.cveq.2005.12.025_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02801966","article-title":"Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats","volume":"106","author":"Jeste","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cveq.2005.12.025_bib12","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"361","article-title":"Hypnotics","author":"Hobbs","year":"1996"},{"key":"10.1016\/j.cveq.2005.12.025_bib13","unstructured":"Gimenez T, Gimenez RM, Stafford KB, et al. How to safely manage a potentially rabid equine. Presented at the 49th Annual American Association of Equine Practitioners Convention, New Orleans, LA, 2003."},{"key":"10.1016\/j.cveq.2005.12.025_bib14","unstructured":"Sommardahl CS. Rabies. In: Reed SM, Bayly WM, Sellon DC, editors. Equine internal medicine. St. Louis: Saunders: St. Louis; 2004. p. 644\u20136."},{"key":"10.1016\/j.cveq.2005.12.025_bib15","series-title":"Equine internal medicine","first-page":"1441","article-title":"Toxicologic problems","author":"Schmitz","year":"2004"},{"key":"10.1016\/j.cveq.2005.12.025_bib16","series-title":"Veterinary neuropathology","first-page":"270","article-title":"Equine leukoencephalomalacia","author":"Summers","year":"1995"},{"key":"10.1016\/j.cveq.2005.12.025_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1939-1676.2004.tb00165.x","article-title":"Neurologic abnormalities and cerebrospinal fluid changes in horses administered fumonisin B1 intravenously","volume":"18","author":"Foreman","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cveq.2005.12.025_bib18","first-page":"44","article-title":"West Nile Virus continues to gain ground in the United States","author":"Brashier","year":"2002","journal-title":"DVM Newsmagazine Suppl\u2013DVM In Focus"},{"key":"10.1016\/j.cveq.2005.12.025_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2460\/javma.2004.225.84","article-title":"Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses","volume":"225","author":"Ward","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2005.12.025_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1354\/vp.38-4-451","article-title":"Clinical, pathologic, immunohistochemical, and virologic findings of Eastern Equine Encephalomyelitis in two horses","volume":"38","author":"del Piero","year":"2001","journal-title":"Vet Pathol"},{"key":"10.1016\/j.cveq.2005.12.025_bib21","series-title":"Equine internal medicine","first-page":"631","article-title":"Togaviral encephalitis","author":"Bertone","year":"2004"},{"key":"10.1016\/j.cveq.2005.12.025_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1354\/vp.38-4-414","article-title":"Pathologic and immunohistochemical findings in naturally occurring West Nile Virus infection in horses","volume":"38","author":"Cantile","year":"2001","journal-title":"Vet Pathol"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073905000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073905000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:07:08Z","timestamp":1760069228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073905000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0749073905000957"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2005.12.025","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluphenazine-Induced Extrapyramidal Side Effects in a Horse","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2005.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}